Form 4: BridgeBio Pharma CFO Thomas Trimarchi Disposes of Shares to Cover Tax Obligations

Thomas Trimarchi, CFO of BridgeBio Pharma, disposed of 21,317 shares of common stock to satisfy tax obligations related to vesting restricted stock units.

Summary

• On May 16, 2025, Thomas Trimarchi, the President and CFO of BridgeBio Pharma, disposed of 21,317 shares of the company's common stock.
• The transaction was executed to cover the reporting person's tax obligations associated with the vesting of 38,545 shares of common stock underlying restricted stock units.
• The shares were disposed of at a price of $33.84 per share.
• Following the transaction, Trimarchi directly owns 501,988 shares of BridgeBio Pharma.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Form 4 filings are a routine part of insider trading activity and are required by the SEC to ensure transparency in the market. This filing indicates that a company insider has made a transaction in the company's stock.

Key Dates

Keywords

Form 4, BridgeBio Pharma, BBIO, Thomas Trimarchi, CFO, Stock Disposal, Tax Obligations, Restricted Stock Units, Beneficial Ownership